[Skip to Content]
[Skip to Content Landing]
JAMA Clinical Guidelines Synopsis
June 19, 2018

Glycemic Control in Nonpregnant Adults With Type 2 Diabetes

Author Affiliations
  • 1Chicago Center for Diabetes Translation Research, Section of General Internal Medicine, University of Chicago, Chicago, Illinois
JAMA. 2018;319(23):2430-2431. doi:10.1001/jama.2018.6798

In the United States, type 2 diabetes affects 30 million people and is a major cause of morbidity and mortality.1 Glycemic control has been shown to reduce diabetes complications, particularly for microvascular disease.2,3 However, increasing recognition of adverse events due to intensive diabetes treatments has prompted major disagreements about optimal glycemic targets.